NovaDel’s USPTO Allowance Notice (AMEX:NVD)
Jay Garcilazo (November 6th, 2009) Writes:
NovaDel Pharma Inc. (AMEX:NVD) announced that they have received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for claims under U.S. Patent Application No. 10/671,715 entitled “Buccal, Polar and Non-Polar Spray containing Zolpidem” that covers a method of treating insomnia by administering zolpidem to human beings utilizing NovaMist Oral Spray spray technology. NovaDel’s oral spray technology is focused for unmet medical needs for a broad array of existing and future pharmaceutical products. The Company’s most advanced oral spray candidates target angina, nausea, insomnia, migraine headaches and disorders of the central nervous system.
NovaDel Pharma is a leading specialty pharmaceutical company that is into the development of oral spray formulations for a broad range of marketed drugs. The Company offers conventional oral dosage forms that has the potential for faster absorption of drugs into the bloodstream that leads to quick therapeutic effects and reduces first pass
...angina, Biotech, FavStocks, Food And Drug Administration, insomnia, Investing Lessons, migraine headaches;, nausea, NovaDel Pharma Inc., NovaMist, NovaMist oral, NovaMist Oral Spray spray technology, oral spray, oral spray technology, Pharmaceutical, Pharmaceutical Products, Spray, spray technology, Stocks to Watch, treatment of insomnia, United States Patent and Trademark Office;, zolpidem


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)


